Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Cytokine
|
August 12, 2019
WHO International Standards and reference preparations for cytokines and growth factors
Amanda Proudfoot, Meenu Wadhwa
Methods in Enzymology
|
February 29, 2016
Methods for the Recognition of GAG-Bound Chemokines
Pauline Bonvin, Franck Gueneau, Nicolas Fischer, et al.
Methods in Enzymology
|
February 29, 2016
Mutagenesis by Phage Display
Pauline Bonvin, Christine Power, Amanda Proudfoot, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 5, 2008
A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice
Vincent Braunersreuther, Sabine Steffens, Claire Arnaud, et al.
Kidney International
|
February 19, 2002
Early application of Met-RANTES ameliorates chronic allograft nephropathy
Erwei Song, Hequn Zou, Yousheng Yao, et al.
Circulation
|
March 19, 2008
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice
Christophe Combadière, Stéphane Potteaux, Mathieu Rodero, et al.
Journal of Molecular and Cellular Cardiology
|
August 12, 2009
Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice
Vincent Braunersreuther, Corinne Pellieux, Graziano Pelli, et al.
The Journal of Biological Chemistry
|
December 6, 2002
The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle
Cédric Blanpain, Benjamin J Doranz, Antoine Bondue, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 21, 2010
Discovery of a novel series of CXCR3 antagonists
Stefano Crosignani, Marc Missotten, Christophe Cleva, et al.
Journal of Hepatology
|
December 25, 2016
Functional role of CCL5/RANTES for HCC progression during chronic liver disease
Antje Mohs, Nadine Kuttkat, Johanna Reißing, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Cytokine
|
August 12, 2019
WHO International Standards and reference preparations for cytokines and growth factors
Amanda Proudfoot, Meenu Wadhwa
Methods in Enzymology
|
February 29, 2016
Methods for the Recognition of GAG-Bound Chemokines
Pauline Bonvin, Franck Gueneau, Nicolas Fischer, et al.
Methods in Enzymology
|
February 29, 2016
Mutagenesis by Phage Display
Pauline Bonvin, Christine Power, Amanda Proudfoot, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 5, 2008
A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice
Vincent Braunersreuther, Sabine Steffens, Claire Arnaud, et al.
Kidney International
|
February 19, 2002
Early application of Met-RANTES ameliorates chronic allograft nephropathy
Erwei Song, Hequn Zou, Yousheng Yao, et al.
Circulation
|
March 19, 2008
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice
Christophe Combadière, Stéphane Potteaux, Mathieu Rodero, et al.
Journal of Molecular and Cellular Cardiology
|
August 12, 2009
Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice
Vincent Braunersreuther, Corinne Pellieux, Graziano Pelli, et al.
The Journal of Biological Chemistry
|
December 6, 2002
The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle
Cédric Blanpain, Benjamin J Doranz, Antoine Bondue, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 21, 2010
Discovery of a novel series of CXCR3 antagonists
Stefano Crosignani, Marc Missotten, Christophe Cleva, et al.
Journal of Hepatology
|
December 25, 2016
Functional role of CCL5/RANTES for HCC progression during chronic liver disease
Antje Mohs, Nadine Kuttkat, Johanna Reißing, et al.
Page
of 2